Compare Abeona Therapeutics Inc (ABEO) vs Equinor ASA (EQNR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Equinor ASA — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Equinor ASA trades at $40.81 (market cap $97.58B). The key difference: Equinor ASA is far larger — about 231.7× Abeona Therapeutics Inc's market cap, and Equinor ASA pays a 3.81% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | EQNR | |
|---|---|---|
Market Cap | $421.19M | $97.58B |
Sector | Health | Energy |
52-Week High | $7.45 | $42.40 |
52-Week Low | $4.17 | $22.41 |
Enterprise Value | $276.10M | $106.28B |
Dividend Yield | — | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →
